R J Stark
Overview
Explore the profile of R J Stark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamborska A, Wood G, Westenberg E, Garcia-Azorin D, Webb G, Schiess N, et al.
J Neurol Sci
. 2023 Jun;
451:120709.
PMID: 37385027
No abstract available.
2.
Tamborska A, Wood G, Westenberg E, Garcia-Azorin D, Webb G, Schiess N, et al.
J Neurol Sci
. 2023 Apr;
449:120646.
PMID: 37100018
Introduction: Uniform case definitions are required to ensure harmonised reporting of neurological syndromes associated with SARS-CoV-2. Moreover, it is unclear how clinicians perceive the relative importance of SARS-CoV-2 in neurological...
3.
Tam C, Galanos J, Seymour J, Pitman A, Stark R, Prince H
Am J Hematol
. 2004 Aug;
77(1):72-6.
PMID: 15307110
Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon but distinctive clinicoradiological entity comprising of headache, seizures, visual disturbance, and altered mental function, in association with posterior cerebral white matter edema....
4.
Williams D, Stark R
Cephalalgia
. 2004 Feb;
23(10):963-71.
PMID: 14984229
Patients with chronic daily headache with medication overuse are difficult to treat, especially when the doses of analgesia are substantial. We have previously shown that intravenous lignocaine (lidocaine) infusion is...
5.
Hand P, Stark R
Med J Aust
. 2000 Apr;
172(4):157-9.
PMID: 10772585
Objectives: To determine the safety and efficacy of intravenous lignocaine infusion in patients with severe chronic daily headache (CDH). Design: Retrospective survey of consecutive patients. Participants: 19 patients, 18 with...
6.
Faragher M, Stark R
J Clin Neurosci
. 1997 Apr;
4(2):252-5.
PMID: 18638965
This case illustrates the features of Hunter syndrome (mucopolysaccharidosis type 2) complicated by hydrocephalus and a prolonged activated partial thromboplastin time (APTT). Ventriculo-peritoneal shunt insertion was performed but was complicated...
7.
8.
Thyagarajan D, Bastian I, Stark R, Day B, Dax E, GILLIGAN B
Med J Aust
. 1993 Jul;
159(1):29-31.
PMID: 8316110
Objective: To describe the clinical and laboratory features of human T-lymphotropic virus type I (HTLV-I) associated myelopathy in an immigrant from the Seychelles. Clinical Features: A slowly progressive myelopathy has...
9.
Thyagarajan D, Stark R, Frayne J, GILLIGAN B, Sacharias N
Clin Exp Neurol
. 1992 Jan;
29:129-42.
PMID: 1343857
Since 1983 at the Alfred Hospital 4 patients with thrombotic or embolic vertebrobasilar occlusions have been treated with intra-arterial streptokinase (SK) infusions for the effects of persisting brainstem ischaemia despite...
10.
Halmagyi G, Brandt T, Dieterich M, Curthoys I, Stark R, Hoyt W
Neurology
. 1990 Oct;
40(10):1503-9.
PMID: 2215939
We studied 4 patients with tonic contraversive ocular tilt reactions due to unilateral, paramedian, mesodiencephalic lesions. This is in contrast to the only 2 previously reported patients with ocular tilt...